Do Clinical Trials Fit in a Private Medical Practice?

por Nahass, Ronald
Publicado 2014

467. Investigation of a Clostridium difficile Infection (CDI) Outbreak in a Community Teaching Hospital

por Parker, Laura, Parrillo, Sharon, Nahass, Ronald
Publicado 2018

Impact of tocilizumab administration on mortality in severe COVID-19

por Tsai, Andrew, Diawara, Oumou, Nahass, Ronald G., Brunetti, Luigi
Publicado 2020

Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis

por Hong, Thomas S., Gonzalez, Jimmy, Nahass, Ronald G., Brunetti, Luigi
Publicado 2020

615. A Year with COVID19 – Experience from the Front Line in a Large Infectious Disease (ID) Clinical Practice

por Nahass, Ronald G, Giordano, Angelo, McManus, Edward J
Publicado 2021

Successful Treatment of Cutibacterium acnes Prosthetic Joint Infection With Single-Stage Exchange and Oral Antibiotics

por Kohm, Kevin, Seneca, Kathleen, Smith, Krystle, Heinemann, Danielle, Nahass, Ronald G
Publicado 2023

The Association of Serotonin Toxicity with Combination Linezolid–Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis

por SanFilippo, Savanna, Turgeon, Jacques, Michaud, Veronique, Nahass, Ronald G., Brunetti, Luigi
Publicado 2023

814. Successful Treatment of Cutibacterium acnes (CA) Prosthetic Device Infection (PDI) with Oral Linezolid and Rifampin (LR)

por Nahass, Ronald G, Esquivel, Maalikat, Smith, Krystle, Heinemann, Danielle, Seneca, Kathleen H
Publicado 2021

512. Does Time From COVID-19 Symptom Onset to Administration of Anti-spike Protein Monoclonal Antibody Predict Response?

por SanFilippo, Savanna, Crovetto, Brynna, Milano, Marc, Bucek, John, Nahass, Ronald G, Brunetti, Luigi
Publicado 2021

Comparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis

por San Filippo, Savanna, Crovetto, Brynna, Bucek, John, Nahass, Ronald G, Milano, Marc, Brunetti, Luigi
Publicado 2022

Linkage to Care for Suburban Heroin Users with Hepatitis C Virus Infection, New Jersey, USA

por Akyar, Eda, Seneca, Kathleen H., Akyar, Serra, Schofield, Neal, Schwartz, Mark P., Nahass, Ronald G.
Publicado 2016

Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19

por Brunetti, Luigi, Diawara, Oumou, Tsai, Andrew, Firestein, Bonnie L., Nahass, Ronald G., Poiani, George, Schlesinger, Naomi
Publicado 2020

Relationship between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin–Preclinical and Clinical Evidence

por Brunetti, Luigi, Chapy, Helene, Nahass, Ronald G., Moore, Rebecca, Wassef, Andrew, Adler, Derek, Yurkow, Edward, Kagan, Leonid
Publicado 2023

Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older

por Flamm, Steven, Peng, Cheng-Yuan, Shibolet, Oren, Nahass, Ronald, Hwang, Peggy, Barr, Eliav, Robertson, Michael N., Haber, Barbara A.
Publicado 2019

2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic

por Akyar, Eda, Mora, Nallely, Luke, Amy, Layden, Jennifer, Phillips, Richard, Agyarko-Poku, Thomas, Owusu, Dorcas, A-Siaw, Helena, Nahass, Ronald
Publicado 2018

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study

por Kwo, Paul, Gitlin, Norman, Nahass, Ronald, Bernstein, David, Etzkorn, Kyle, Rojter, Sergio, Schiff, Eugene, Davis, Mitchell, Ruane, Peter, Younes, Ziad, Kalmeijer, Ronald, Sinha, Rekha, Peeters, Monika, Lenz, Oliver, Fevery, Bart, De La Rosa, Guy, Scott, Jane, Witek, James
Publicado 2016

The emergence of NS5B resistance associated substitution S282T after sofosbuvir‐based treatment

por Gane, Edward J., Metivier, Sophie, Nahass, Ronald, Ryan, Michael, Stedman, Catherine A., Svarovskaia, Evguenia S., Mo, Hongmei, Doehle, Brian, Dvory‐Sobol, Hadas, Hedskog, Charlotte, Lin, Ming, Brainard, Diana M., Yang, Jenny C., McHutchison, John G., Sulkowski, Mark, Younes, Ziad, Lawitz, Eric
Publicado 2017

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

por Janssen, Harry L A, Hou, Jinlin, Asselah, Tarik, Chan, Henry L Y, Zoulim, Fabien, Tanaka, Yasuhito, Janczewska, Ewa, Nahass, Ronald G, Bourgeois, Stefan, Buti, Maria, Lampertico, Pietro, Lenz, Oliver, Verbinnen, Thierry, Vandenbossche, Joris, Talloen, Willem, Kalmeijer, Ronald, Beumont, Maria, Biermer, Michael, Shukla, Umesh
Publicado 2023

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

por Goldman, Jason D., Lye, David C.B., Hui, David S., Marks, Kristen M., Bruno, Raffaele, Montejano, Rocio, Spinner, Christoph D., Galli, Massimo, Ahn, Mi-Young, Nahass, Ronald G., Chen, Yao-Shen, SenGupta, Devi, Hyland, Robert H., Osinusi, Anu O., Cao, Huyen, Blair, Christiana, Wei, Xuelian, Gaggar, Anuj, Brainard, Diana M., Towner, William J., Muñoz, Jose, Mullane, Kathleen M., Marty, Francisco M., Tashima, Karen T., Diaz, George, Subramanian, Aruna
Publicado 2020